Sign In
Buy KYTX
$7.82
-0.0800 (-1.01%)
At Close: Jun 03, 2026
February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX
05:00pm, Wednesday, 11'th Dec 2024
NEW YORK, NY / ACCESSWIRE / December 11, 2024 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securi
NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed ag
SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) common stock pursuant and/or traceable
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Kyverna Therapeutics, Inc. - KYTX
12:00pm, Wednesday, 11'th Dec 2024
NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Kyverna Therapeutics, Inc. ("Kyverna" or the "Company") (NASDAQ:KYTX). Such i
KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
10:12am, Wednesday, 11'th Dec 2024
LOS ANGELES , Dec. 11, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against Kyverna Therapeutics, Inc.
NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Kyverna Ther
NEW ORLEANS, La.--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 7, 202
The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Kyverna Therapeutics Inc
08:00pm, Tuesday, 10'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against Kyverna Therapeutics,
Investors can contact the law firm at no cost to learn more about recovering their losses
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of Kyverna Therapeutics, Inc. (N
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc.
03:23pm, Tuesday, 10'th Dec 2024
SAN DIEGO , Dec. 10, 2024 /PRNewswire/ -- Robbins LLP announces that a shareholder filed a class action against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and certain of the Company's senior executive
KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) INVESTOR ALERT: Investors With Large Losses in Kyverna Therapeutics, Inc. Should Contact Bernstein Liebhard LLP
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Kyverna Therapeutics, Inc. (KYTX)
02:26pm, Tuesday, 10'th Dec 2024
NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of C
NEW YORK, NY / ACCESSWIRE / December 10, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Kyverna Ther
KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
01:37pm, Tuesday, 10'th Dec 2024
LOS ANGELES--(BUSINESS WIRE)--KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm.
